611 related articles for article (PubMed ID: 26520899)
1. Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies.
Pirillo A; Catapano AL
Atherosclerosis; 2015 Dec; 243(2):449-61. PubMed ID: 26520899
[TBL] [Abstract][Full Text] [Related]
2. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.
Kong W; Wei J; Abidi P; Lin M; Inaba S; Li C; Wang Y; Wang Z; Si S; Pan H; Wang S; Wu J; Wang Y; Li Z; Liu J; Jiang JD
Nat Med; 2004 Dec; 10(12):1344-51. PubMed ID: 15531889
[TBL] [Abstract][Full Text] [Related]
3. Combination of simvastatin with berberine improves the lipid-lowering efficacy.
Kong WJ; Wei J; Zuo ZY; Wang YM; Song DQ; You XF; Zhao LX; Pan HN; Jiang JD
Metabolism; 2008 Aug; 57(8):1029-37. PubMed ID: 18640378
[TBL] [Abstract][Full Text] [Related]
4. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.
Zhang H; Wei J; Xue R; Wu JD; Zhao W; Wang ZZ; Wang SK; Zhou ZX; Song DQ; Wang YM; Pan HN; Kong WJ; Jiang JD
Metabolism; 2010 Feb; 59(2):285-92. PubMed ID: 19800084
[TBL] [Abstract][Full Text] [Related]
5. Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption.
Wang Y; Yi X; Ghanam K; Zhang S; Zhao T; Zhu X
Metabolism; 2014 Sep; 63(9):1167-77. PubMed ID: 25002181
[TBL] [Abstract][Full Text] [Related]
6. Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment.
Pisciotta L; Bellocchio A; Bertolini S
Lipids Health Dis; 2012 Sep; 11():123. PubMed ID: 22998978
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of ETC-1002, a novel investigational low-density lipoprotein-cholesterol-lowering therapy for the treatment of patients with hypercholesterolemia and type 2 diabetes mellitus.
Gutierrez MJ; Rosenberg NL; Macdougall DE; Hanselman JC; Margulies JR; Strange P; Milad MA; McBride SJ; Newton RS
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):676-83. PubMed ID: 24385236
[TBL] [Abstract][Full Text] [Related]
8. Berberine--a novel approach to cholesterol lowering.
Doggrell SA
Expert Opin Investig Drugs; 2005 May; 14(5):683-5. PubMed ID: 15926873
[TBL] [Abstract][Full Text] [Related]
9. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.
Wang Y; Campbell T; Perry B; Beaurepaire C; Qin L
Metabolism; 2011 Feb; 60(2):298-305. PubMed ID: 20304443
[TBL] [Abstract][Full Text] [Related]
10. The safety and anti-hypercholesterolemic effect of coptisine in Syrian golden hamsters.
He K; Ye X; Wu H; Wang Y; Zou Z; Ning N; Hu Y; Chen B; Fang X; Li X
Lipids; 2015 Feb; 50(2):185-94. PubMed ID: 25547428
[TBL] [Abstract][Full Text] [Related]
11. Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein efflux.
Shan YQ; Ren G; Wang YX; Pang J; Zhao ZY; Yao J; You XF; Si SY; Song DQ; Kong WJ; Jiang JD
Metabolism; 2013 Mar; 62(3):446-56. PubMed ID: 23079743
[TBL] [Abstract][Full Text] [Related]
12. A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome.
Wei W; Zhao H; Wang A; Sui M; Liang K; Deng H; Ma Y; Zhang Y; Zhang H; Guan Y
Eur J Endocrinol; 2012 Jan; 166(1):99-105. PubMed ID: 22019891
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients.
Marazzi G; Cacciotti L; Pelliccia F; Iaia L; Volterrani M; Caminiti G; Sposato B; Massaro R; Grieco F; Rosano G
Adv Ther; 2011 Dec; 28(12):1105-13. PubMed ID: 22113535
[TBL] [Abstract][Full Text] [Related]
14. Synergetic cholesterol-lowering effects of main alkaloids from Rhizoma Coptidis in HepG2 cells and hypercholesterolemia hamsters.
Kou S; Han B; Wang Y; Huang T; He K; Han Y; Zhou X; Ye X; Li X
Life Sci; 2016 Apr; 151():50-60. PubMed ID: 26876917
[TBL] [Abstract][Full Text] [Related]
15. The natural compound berberine positively affects macrophage functions involved in atherogenesis.
Zimetti F; Adorni MP; Ronda N; Gatti R; Bernini F; Favari E
Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):195-201. PubMed ID: 25240689
[TBL] [Abstract][Full Text] [Related]
16. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
17. Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials.
Derosa G; Maffioli P; Cicero AF
Expert Opin Biol Ther; 2012 Aug; 12(8):1113-24. PubMed ID: 22780092
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Nutraceutical Combination of Monacolin K, Berberine, and Silymarin on Lipid Profile and PCSK9 Plasma Level in a Cohort of Hypercholesterolemic Patients.
Formisano E; Pasta A; Cremonini AL; Favari E; Ronca A; Carbone F; Semino T; Di Pierro F; Sukkar SG; Pisciotta L
J Med Food; 2020 Jun; 23(6):658-666. PubMed ID: 31663806
[TBL] [Abstract][Full Text] [Related]
19. Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells.
Zhou Y; Cao S; Wang Y; Xu P; Yan J; Bin W; Qiu F; Kang N
Fitoterapia; 2014 Jan; 92():230-7. PubMed ID: 24321576
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR's cholesterol-decreasing efficacy in patients.
Wu C; Zhao Y; Zhang Y; Yang Y; Su W; Yang Y; Sun L; Zhang F; Yu J; Wang Y; Guo P; Zhu B; Wu S
J Adv Res; 2022 Mar; 37():197-208. PubMed ID: 35499044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
